Anne Prener
CIK 1797917 · last filed 2025-06-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
12
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 6 | 2025-06-20 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | — | $0.08 | — | $0 | 3 | 2022-05-13 |
| Kaleido Biosciences, Inc. (KLDO) Delisted | Director | — | $0.29 | — | $0 | 3 | 2021-07-01 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-03 | Kaleido Biosciences, Inc. (KLDO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.